Research Group on Women Health
Reproductive Medicine Area
The group is positioned in the field of healthy ageing, particularly in what relates women, with special interest to frailty, where it has collaborated in the support of INCLIVA in the project ADVANTAGE
We have collaborated to position the reference site of the Valencia Region within EIPAHA, the partnership of the European Commission
Moreover, we have participated in the application to different European projects with groups from different European countries, including an application to the Maire Curie grants
Coordinator
STAFF
Collaborating Researchers
Aitana Monllor TormosRocío Belda Montesinos
Nurse
Alicia García Vigara
Technicians
Administrative assistant
Publications
Fezolinetant impact on health-related quality of life for vasomotor symptoms due to the menopause: pooled data from SKYLIGHT 1 and SKYLIGHT 2 randomised controlled trials. Cano A, Nappi R, Santoro N, Stute P, Blogg M, English M, Morga A, Scrine L, Siddiqui E, Ottery F. BJOG-An International Journal of Obstetrics and Gynaecology. 2024 Feb 6. doi: 10.1111/1471-0528.17773. PMID: 38320967
Breaking down barriers for prescribing and using hormone therapy for the treatment of menopausal symptoms: an experts’ perspective. Rozenberg S, Panay N, Gambacciani M, Cano A, Gray S, Schaudig K. Expert Review of Clinical Pharmacology. 2023 Jan-Jun;16(6):507-517. doi: 10.1080/17512433.2023.2219056. PMID: 37278023
Corrigendum to “Evaluation of the impact, treatment patterns, and patient and physician perceptions of vasomotor symptoms associated with menopause in Europe and the United States” [Maturitas 164 (October 2022) 38-45]. Stute P, Cano A, Thurston RC, Small M, Lee L, Scott M, Siddiqui E, Schultz NM. Maturitas. 2023 Mar;169:55. doi: 10.1016/j.maturitas.2022.11.003. PMID: 36435689
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lederman S, Ottery F, Cano A, Santoro N, Shapiro M, Stute P, Thurston R, English M, Franklin C, Lee M, Neal-Perry G. Lancet. 2023 Apr 1;401(10382):1091-1102. doi: 10.1016/S0140-6736(23)00085-5. PMID: 36924778
Genetic variants of the vitamin D receptor are related to dynapenia in postmenopausal women. Garcia-Vigara A, Monllor-Tormos A, Garcia-Perez M, Tarin J, Cano A. Maturitas. 2023 May;171:40-44. doi: 10.1016/j.maturitas.2023.03.002. PMID: 37001478
Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group. Mendoza N, Ramirez I, de la Viuda E, et al. Maturitas. 2022 Aug 30;166:65-85. doi: 10.1016/j.maturitas.2022.08.008. PMID: 36081216
Evaluation of the impact, treatment patterns, and patient and physician perceptions of vasomotor symptoms associated with menopause in Europe and the United States. Stute P, Cano A, Thurston R, Small M, Lee L, Scott M, Siddiqui E, Schultz N. Maturitas. 2022 Jun 23;164:38-45. doi: 10.1016/j.maturitas.2022.06.008. PMID: 35785563
Histological grade and tumor stage are correlated with expression of receptor activator of nuclear factor Kappa b (Rank) in epithelial ovarian cancers. Gomez R, Tejada M, Rodriguez-Garcia V, Burgues O, Santos-Llamas A, Martinez-Massa A, Marin-Montes A, Tarin J, Cano A. International Journal of Molecular Sciences. 2022 Feb 3;23(3):1742. doi: 10.3390/ijms23031742. PMID: 35163671
Identification of Altered Evoked and Non-Evoked Responses in a Heterologous Mouse Model of Endometriosis-Associated Pain. Tejada MA, Santos Llamas A, Escriva L, Tarin JJ, Cano A, Fernandez Ramirez MJ, Nunez Badinez P, De Leo B, Saunders PTK, Vidal V, Barthas F, Vincent K, Sweeney PJ, Sillito RR, Armstrong JD, Nagel J, Gomez R. Biomedicines. 2022 Feb 21;10(2):501. doi: 10.3390/biomedicines10020501. PMID: 35203710
Bazedoxifene increases the proliferation of human arterial endothelial cells but does not affect the expression of cyclins A, B, and D1 and of p27(Kip1). Dudenko D, Gomez R, Garcia-Perez M, Tarin J, Cano A. Gynecological Endocrinology. 2021 Mar;37(3):269-272. doi: 10.1080/09513590.2021.1876653. PMID: 33480311
Comparison of IOTA three-step strategy and logistic regression model LR2 for discriminating between benign and malignant adnexal masses. Hidalgo JJ, Llueca A, Zolfaroli I, Veiga N, Ortiz E, Alcazar JL. Medical Ultrasonography. 2021 May 20;23(2):168-175. doi: 10.11152/mu-2732. PMID: 33626112
Female genital mutilation consequences and healthcare received among migrant women: a phenomenological qualitative study. Gonzalez-Timoneda A, Gonzalez-Timoneda M, Cano Sanchez A, Ruiz Ros V. International Journal of Environmental Research and Public Health. 2021 Jul 5;18(13):7195. doi: 10.3390/ijerph18137195. PMID: 34281134
Global consensus recommendations on menopause in the workplace: a European Menopause and Andropause Society (EMAS) position statement. Rees M, Bitzer J, Cano A, Ceausu I, Chedraui P, Durmusoglu F, Erkkola R, Geukes M, Godfrey A, Goulis DG, Griffiths A, Hardy C, Hickey M, Hirschberg AL, Hunter M, Kiesel L, Jack G, Lopes P, Mishra G, Oosterhof H, Pines A, Riach K, Shufelt C, van Trotsenburg M, Weiss R, Lambrinoudaki I. Maturitas. 2021 Sep;151:55-62. doi: 10.1016/j.maturitas.2021.06.006. PMID: 34274202
Projects
Title: Patrones dietéticos en población europea senescente: acercamiento multidisciplinar para combatir las enfermedades metabólicas ligadas a sobrepeso. Proyecto EURODIET
Funding body: European Commission (Programación conjunta internacional ISCIII)
Principal Investigator: Antonio Cano Sánchez
Duration: 2020 – 2022
Total budget: 27225
Title: EURODIET Dietary Patterns in the Ageing European Population: an Interdisciplinary Approach to combat Overweight-Related Metabolic Diseases. The EURODIET project
Funding body: European Commission (Programación conjunta internacional ISCIII)
Principal Investigator: Antonio Cano Sánchez
Duration: 2019 – 2020
Total budget: 455.915,00 €
Title: Evidence-Based Guidance to Scale-up Integrated Care in Europe (VIGOUR)
Funding body: Agencia Ejecutiva de Consumidores, Salud, Agricultura y Alimentación
Principal Investigator: Antonio Cano Sánchez, Juan J. Tarín, Miguel Ángel García Pérez
Duration: 2019 – 2021
Total budget: 3.046.024,67
+ Info
Menopause symptom management in women with dyslipidemias: An EMAS clinical guide. Anagnostis P, Bitzer J, Cano Sanchez A, Ceausu I, Chedraui P, Durmusoglu F, Erkkola R, Goulis D, Hirschberg A, Kiesel L, Lopes P, Pines A, van Trotsenburg M, Lambrinoudaki I, Rees M. Maturitas. 2020 May;135:82-88. doi: 10.1016/j.maturitas.2020.03.007. PMID: 32209279
Doctoral candidate: Carrasco Catena, María Amparo
Director(s): Cano Sánchez, Antonio; Monleón Sancho, Francisco Javier
Date of the defense: 20/11/2020
University: Universitat de València
Title: Efectos de las enfermedades de las mujeres sobre resultados FIV/ICSI y la utilización de probabilidades acumuladas de nacimiento vivo como único método de predicción
Doctoral candidate: Pascual Castelló, Eva Cristina
Director(s): Tarín Folgado, Juan José
Date of the defense: 05/10/2020
University: Universitat de València
Title: Vivencias en relación con la mutilación genital femenina y capacitación para su abordaje desde los diferentes actores institucionales implicados en valencia
Doctoral candidate: González Timoneda, Alba
Director(s): Ruiz Ros, Vicente; Cano Sánchez, Antonio
Date of the defense: 23/07/2020
University: Universitat de València
Title: Impact of bazedoxifene on endothelial health markers
Doctoral candidate: Dudenko Lozenko, Darya
Director(s): Cano Sánchez, Antonio; Tarín Folgado, Juan José; Gómez Gallego, Raúl
Date of the defense: 30/06/2020
University: Universitat de València
Title: Tratamiento del mioma con acetato de ulipristal: control evolutivo con ecografía/angiografía tridimensional
Doctoral candidate: Pascual Botía, Carlos
Director(s): Raga Bauxauli, Francisco; Cano Sánchez, Antonio
Date of the defense: 13/03/2020
University: Universitat de València
Title: Lipidograma y metabolismo óseo, estudio clínico y analítico en la cohorte “CARMEN”
Doctoral candidate: Zolfaroli, Irene
Director(s): García Pérez, Miguel Ángel; Cano Sánchez, Antonio
Date of the defense: 27/02/2019
University: Universitat de València
Title: Evaluación estandarizada del potencial antiangiógénico del agonista dopaminérgico en el tratamiento de la endometriosis
Doctoral candidate: Blanca Ruiz, Taqua
Director(s): Cano Sánchez, Antonio; Gómez Gallego, Raúl
Date of the defense: 17/01/2019
University: Universitat de València